Many terminal cancer patients put false hope in chemo, study finds

October 24, 2012 by Serena Gordon, Healthday Reporter
Many terminal cancer patients put false hope in chemo, study finds
Doctors must improve their message, researchers say.

(HealthDay)—Many people with incurable cancer mistakenly believe chemotherapy may save them, a new study finds.

Researchers at Dana-Farber Cancer Institute in Boston found that more than 80 percent of people with advanced colon cancer and nearly 70 percent with advanced thought chemo could cure their disease. In reality, chemo might give them several more months of life or ease troubling symptoms, but it rarely offers a cure for these diseases once they've spread to distant sites in the body.

"It's really easy for people to have expectations that aren't well aligned with reality," said the study's senior author, Dr. Deborah Schrag, an attending physician in adult oncology at Dana-Farber. "They want to be the one to beat the cancer. And, doctors want to be helpful. We want to be positive.

"What's clear," she added, "is that whatever we're doing right now, we need to change."

These misunderstandings may keep patients from making informed and preparing for death, say the study authors.

The study, published Oct. 25 in the , included almost 1,200 people who were part of the larger Outcomes Research and Surveillance study. The study volunteers were surveyed about four months after their diagnosis with advanced lung or colon cancer—cancer that had spread to other areas of their body (metastasized). Almost all were receiving chemotherapy.

Overall, 69 percent of the and 81 percent with colon cancer reported unrealistic expectations about the likelihood that their chemotherapy might cure them.

People with were more likely to believe that chemo might provide a cure, and blacks and Hispanics were significantly more likely to think that.

Patients who reported having favorable communication with their doctor were also more likely than others to expect a cure, the investigators found.

"You've been dealt a bad hand and, as your doctors, we want to help you cope," said Schrag. "But we may be robbing people of the opportunity to prioritize and make plans for what's important to them. We need to walk a fine line and have our patients hope for what's possible, but plan for what's probable."

Doctors also have to expect their popularity may drop in the face of truthful conversations, the study authors noted.

The co-author of an accompanying editorial, Dr. Thomas J. Smith, said what really matters is what people understand about their disease. "As long as these people are still planning for the worst, it's wonderful if they can be hoping for the best," he said.

Smith, director of palliative medicine at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, said that oncologists often need to change the way they deliver information to help people better understand what they can expect to happen.

"Oncologists like me are pretty good at saying to someone with lung cancer, 'This is something we can't cure.' But, that's very different than saying, 'What do you want to know about your disease?' or 'What do you understand about your disease?'" he said.

Smith said it's also important to have these types of discussions several times during the illness, and when someone has between three and six months left to live, it's important to discuss hospice care.

Misguided expectations also burden taxpayers. One-quarter of Medicare funds—the U.S. insurance program for the elderly—are spent in the year before death, in part because of late-stage chemotherapy, the editorialists noted.

"Chemotherapy can help ease symptoms, and some chemotherapy may extend life, but at some point chemotherapy can do you more harm than good," Smith said.

Schrage added, "It's important to know that is helpful and valuable. It's not worthless by any means. But, hopefully patients will feel empowered to ask, 'How will this help me?' and 'What is realistic for me to expect?'"

She said it's also very helpful to bring someone to your doctor's appointment, because it's often hard to focus on what the doctor is saying after you've been given difficult, life-altering news.

Explore further: Avastin no benefit to older lung cancer patients: study

More information: There's more on chemotherapy at the American Cancer Society.

Related Stories

Avastin no benefit to older lung cancer patients: study

April 17, 2012
(HealthDay) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer Institute report.

Pre-op treatments boost survival for esophageal cancer patients: study

May 30, 2012
(HealthDay) -- Patients with esophageal cancer who receive chemotherapy and radiation before surgery have better outcomes, Dutch researchers report.

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

September 30, 2012
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 ...

Certain head and neck cancer patients benefit from second round of treatment

June 13, 2011
A new study has determined predictors that can better identify patients who will benefit from a potentially toxic second course of treatment, which offers a small but real chance of cure in select patients with head and neck ...

High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy

July 5, 2011
High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

gwrede
1 / 5 (1) Oct 25, 2012
"It's really easy for people to have expectations that aren't well aligned with reality," said the study's senior author, Dr. Deborah Schrag.

Overall, 69 percent of the lung cancer patients and 81 percent with colon cancer reported unrealistic expectations about the likelihood that their chemotherapy might cure them.
I think Dr. Schrag will have a somewhat other opinion the day she's got colon cancer. But for now, while she still is blissfully naive about how it really feels, we have to be patient with her.

Of course it would be easier on us if these cancer patients would go home and start planning their funeral and the color of their coffin. They could also alleviate many survivors lives by settling their disputes with everybody, so that the living don't have to feel bad once they've died.

Let's wait and see what she does when it's her turn.
freethinking
3 / 5 (2) Oct 25, 2012
gwrede, I like your comment let's wait and see what she does when it's her turn.

I think we can both agree that if a patient wants chemo then it should be done.

Personally (yes at this time I don't have cancer that I know of), if given the option of taking chemo to extend my life a few months, I think I would skip it. That is IF it doesn't reduce pain. I'm also in favor of giving a terminal person as much pain killers as they need or want, but thats another story.

Again, this is just me, and as I've said I'm all in favor of patients right to choose what they think is best for them. Death comes to us all, so fighting it for a few extra months in pain I don't think is worth it.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.